Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone
Conditions: Clinical Response; Histopathological Response; Prognosis Intervention: Drug: first-line chemotherapy Sponsors: Peking University People's Hospital; Peking University Shougang Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Chemotherapy | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Sarcomas